Mechanisms of renoprotective action of sodium-glucose cotransporter-2 inhibitors (gliflozins): a clinician’s view
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are a group of drugs that block the enzyme responsible for the reabsorption of glucose and sodium in the proximal part of the nephron. They appeared in clinical practice about a decade ago for the treatment of type 2 diabetes mellitus, but the first...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaslavsky O.Yu.
2023-03-01
|
Series: | Mìžnarodnij Endokrinologìčnij Žurnal |
Subjects: | |
Online Access: | https://iej.zaslavsky.com.ua/index.php/journal/article/view/1240 |